Immersion

Is ketamine as effective as ECT for depression?

Empty treatment chair with folded lavender blanket.

Last updated

Short answer

In one large 2023 trial, yes. Among 403 adults with treatment-resistant depression and no psychosis, intravenous ketamine worked at least as well as electroconvulsive therapy, known as ECT. About 55 percent of the ketamine group responded, compared with 41 percent on ECT. This was a single open-label trial, not the final word.

The research
Anand, A., Mathew, S. J., Sanacora, G., Murrough, J. W., Goes, F. S., et al. (2023). Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. New England Journal of Medicine, volume 388, issue 25, pages 2315 to 2325.
Sample 403 adults with treatment-resistant depression, randomized across five US sites
Published 2023
Journal New England Journal of Medicine
Amit Anand and colleagues ran a head to head trial across five hospital sites in the United States. They enrolled 403 adults whose major depression had not improved with past treatment and who did not have psychosis. People were randomly assigned to a three week course of intravenous ketamine or to electroconvulsive therapy, the older and more established option, known as ECT. The main question was plain. Could ketamine do at least as well as ECT? The answer was yes. A response, meaning depression scores dropped by at least half, happened in 55.4 percent of the ketamine group and 41.2 percent of the ECT group, a difference of 14.2 percentage points. Full remission followed the same pattern, 32.3 percent with ketamine and 20.0 percent with ECT. Ketamine met the bar for being noninferior to ECT, which is the formal way of saying it was not worse. The two treatments came with different burdens. People who had ECT more often reported memory problems and muscle or body aches. People who had ketamine more often felt detached from themselves during treatment, an effect called dissociation. The authors were careful about the limits. The trial was open label, so everyone knew which treatment they were getting, and the ECT arm began with a unilateral form of ECT that some clinicians argued is not the strongest version. So this is one strong trial, not a final verdict.
Read the paper

What does this mean for you?

If you are weighing ketamine against ECT, the headline from this trial is reassuring. For people whose depression has not lifted with other treatments, ketamine held its own against ECT, the option with the longest track record. In plain terms, choosing the newer treatment did not mean settling for a weaker one, at least over the few weeks this trial measured.

What the numbers do not do is make the choice for you. Both treatments helped only some of the people who tried them. Close to half of each group did not reach a response, which is an honest reminder that treatment-resistant depression is hard and no single option works for everyone. The two paths also feel different to go through. ECT more often brought memory effects and body aches. Ketamine more often brought a sense of detachment during the session itself.

Keep the limits in view. This was one open-label trial, so everyone knew which treatment they were getting, and that can shape how people rate their own mood. The comparison also leaned on a lighter form of ECT to start, which some specialists felt was not a fair test of what ECT can do. That does not erase the result, but it does mean this is one strong data point, not the last word. The real decision belongs in a conversation with a clinician who knows your history.

The takeaway

Terms in this page

This is the work Asendar™ was built for: holding steady with you in the days and weeks around an intensive treatment, so changes in how you feel get noticed and carried into your next appointment instead of lost. If you want a simple read on where you are starting from today, take your Mental Readiness Score.

Start free: get your Mental Readiness Score

Your Mental Readiness Score is a short daily check-in on how steady you feel today. Free, web app, no download.

Explore more in the Immersion pillar